MALT1 Recombinant Antibody

$Western blot analysis of Jurkat cell lysate. Using MALT1 (bsm-62898R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n$

Western blot analysis of Jurkat cell lysate. Using MALT1 (bsm-62898R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n

Applications

WB
Flow-Cyt
ICC/IF

Reactivity

Human

Overview
Catalog #	bsm-62898r
Product Name	MALT1 Recombinant Antibody
Applications	WB, Flow-Cyt, ICC/IF
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human MALT1
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	10892
Swiss Prot	Q9UDY8
Synonyms	Malt1; MLT1; Mucosa associated lymphoid tissue lymphoma translocation gene 1; Paracaspase.
Background	Protease that enhances BCL10-induced activation: acts via formation of CBM complexes that channel adaptive and innate immune signaling downstream of CARD domain-containing proteins (CARD9, CARD11 and CARD14) to activate NF-kappa-B and MAP kinase p38 pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines.
Application Dilution
WB	1:300-5000
Flow-Cyt	FCM1:20-100
ICC/IF	IFICC1:50-200